A detailed history of Corton Capital Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 11,782 shares of CELC stock, worth $147,864. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,782
Holding current value
$147,864
% of portfolio
0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $164,712 - $225,625
11,782 New
11,782 $175,000
Q2 2022

Aug 15, 2022

BUY
$5.35 - $10.11 $120,695 - $228,081
22,560 New
22,560 $205,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $188M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.